AST-120 Treatment Alters the Gut Microbiota Composition and Suppresses Hepatic Triglyceride Levels in Obese Mice
Sign Up to like & getrecommendations! Published in 2021 at "Endocrine Research"
DOI: 10.1080/07435800.2021.1927074
Abstract: ABSTRACT Background: The prevalence of nonalcoholic fatty liver disease (NAFLD) has been increasing worldwide. The existence of a relationship between the microbiota and the pathology of hepatic steatosis is also becoming increasingly clear. AST-120, an… read more here.
Keywords: hepatic triglyceride; triglyceride levels; 120 treatment; gut microbiota ... See more keywords